A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease
Public ClinicalTrials.gov record NCT05744401. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Long-term Extension Study to Evaluate the Safety, Tolerability, and Efficacy of AL002 in Participants With Alzheimer's Disease
Study identification
- NCT ID
- NCT05744401
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Alector Inc.
- Industry
- Enrollment
- 197 participants
Conditions and interventions
Conditions
Interventions
- AL002 Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 3, 2023
- Primary completion
- Jan 30, 2025
- Completion
- Feb 4, 2025
- Last update posted
- Feb 24, 2026
2023 – 2025
United States locations
- U.S. sites
- 15
- U.S. states
- 8
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Alzheimer's Institute | Phoenix | Arizona | 85006 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| SFM Clinical Research, LLC | Boca Raton | Florida | 33487 | — |
| Charter Research | Lady Lake | Florida | 32159 | — |
| K2 Medical Research - Maitland | Maitland | Florida | 32751 | — |
| Progressive Medical Research - ClinEdge - PPDS | Port Orange | Florida | 32127 | — |
| Axiom Brain Health LLC | Tampa | Florida | 33609 | — |
| "Alzheimers Research and Treatment Center-Wellington " | Wellington | Florida | 33449 | — |
| Conquest Research LLC - Winter Park - ClinEdge - PPDS | Winter Park | Florida | 32819 | — |
| Hattiesburg Clinic | Hattiesburg | Mississippi | 39401 | — |
| Advanced Clinical Institute | Neptune City | New Jersey | 07753 | — |
| Feinstein Institute For Medical Research | Manhasset | New York | 11030 | — |
| SUNY Upstate Medical Center | Syracuse | New York | 13210 | — |
| University of Cincinnati Medical Center | Cincinnati | Ohio | 45219 | — |
| Summit Research Network | Portland | Oregon | 97210 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05744401, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 24, 2026 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05744401 live on ClinicalTrials.gov.